focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCP Infrastructure Investments Regulatory News (GCP)

Share Price Information for GCP Infrastructure Investments (GCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 76.60
Bid: 76.10
Ask: 76.90
Change: 0.60 (0.79%)
Spread: 0.80 (1.051%)
Open: 77.50
High: 77.50
Low: 76.00
Prev. Close: 76.00
GCP Live PriceLast checked at -
GCP Infrastructure Investments is an Investment Trust

To provide shareholders with regular, sustainable, long-term dividend income and to preserve the capital value of its investments over the long term by generating exposure to infrastructure debt and/or similar assets.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing under the Placing Programme

6 Jul 2016 12:21

RNS Number : 4289D
GCP Infrastructure Investments Ltd
06 July 2016
 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO U.S. PERSONS OR INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

This announcement is an advertisement and not a prospectus. Any decision to invest in any securities referred to in this announcement must be made exclusively on the basis of the prospectus published by the Company on 18 April 2016 in connection with a placing programme (the "Placing Programme") for ordinary shares of £0.01 each ("Ordinary Shares"), to be admitted to the Premium Listing segment of the Official List of the UK Listing Authority and to trading on the Main Market for listed securities of the London Stock Exchange (the "Prospectus"). A copy of the Prospectus is available for inspection at www.morningstar.co.uk/uk/NSM. This announcement does not constitute a recommendation regarding any securities.

 6 July 2016

 

GCP Infrastructure Investments Limited

(the "Company")

Placing under the Placing Programme

 

Further to the announcement on 4 July 2016 by the Company of a placing of new Ordinary Shares under the Placing Programme (the "Placing") in accordance with the Prospectus, the Company's Investment Adviser, Gravis Capital Partners LLP, has identified additional investment opportunities in accordance with the Company's investment objective and policy.

Accordingly, the Board has resolved to increase the size of the Placing to up to £50 million. The Board, in its discretion and subject to the availability of suitable investment opportunities, reserve the right to increase the size of the Placing up to a maximum of £75 million.

The timetable and the Placing Price of 116.5 pence per new Ordinary Share remain as set out in the announcement of 4 July 2016. The timetable has been reproduced below.

 

Expected timetable 

2016

Latest time and date for receipt of placing commitments

12:00 p.m. on 8 July

Results of Placing announced and trade date

8 July

Admission and Settlement

8:00 a.m. on 12 July

 

Unless otherwise defined herein, terms used in this announcement shall have the same meanings as those defined in the Prospectus of the Company dated 18 April 2016.

 

For further information, please contact:

 

Gravis Capital Partners LLP

Stephen Ellis

Rollo Wright

Dion Di Miceli

 

+44 (0)20 7518 1490

 

Stifel Nicolaus Europe Limited

Neil Winward

Mark Bloomfield

Tunga Chigovanyika

 

 

+44 (0)20 7710 7600

Buchanan

Charles Ryland

Victoria Hayns

 

+44 (0)20 7466 5000

Important Information

Members of the public are not eligible to take part in the Placing. This announcement and the terms and conditions referred to herein are directed in the United Kingdom only at persons selected by Stifel Nicolaus Europe Limited who are "investment professionals" falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "FPO") or "high net worth companies, unincorporated associations etc" falling within Article 49(2) of the FPO, or persons to whom it may otherwise be lawfully communicated (all such persons together being referred to as "Relevant Persons"). This announcement and the terms and conditions referred to herein must not be acted on or relied on in the United Kingdom by persons who are not Relevant Persons. Any investment or investment activity to which this announcement relates is available only to, and will be engaged in only with, persons in the United Kingdom who are Relevant Persons. 

The new Ordinary Shares that are the subject of the Placing are not being offered or sold to any person in the European Union, other than to "qualified investors" as defined in Article 2.1(e) of Directive 2003/71/EC, which includes legal entities which are regulated by the Financial Conduct Authority or entities which are not so regulated whose corporate purpose is solely to invest in securities. 

This announcement is not for distribution, directly or indirectly, in or into the United States of America (including its territories and possessions, any state of the United States of America and the District of Columbia) (the "United States"), Australia, Canada, Japan or South Africa or into any other jurisdiction where applicable laws prohibit its release, distribution or publication. This announcement does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase, any securities in the United States, Australia, Canada, Japan or South Africa or in any other jurisdiction where such offer or sale would be unlawful. The securities of the Company have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or the US Investment Company Act of 1940, as amended and may not be offered or sold directly or indirectly in or into the United States or to or for the account or benefit of any US Person (within the meaning of Regulation S under the Securities Act). The securities referred to herein have not been registered under the applicable securities laws of Australia, Canada, Japan or South Africa and, subject to certain exceptions, may not be offered or sold within Australia, Canada, Japan or South Africa or to any national, resident or citizen of Australia, Canada, Japan or South Africa. 

This announcement has been issued by and is the sole responsibility of the Company. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by, Stifel Nicolaus Europe Limited or by any of its affiliates or agents as to or in relation to the accuracy or completeness of this announcement or any other written or oral information made available to or publicly available to any interested party or their advisers and any liability therefore is expressly disclaimed. 

Stifel Nicolaus Europe Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as sole broker and bookrunner to the Company and is acting for no-one else in connection with the Placing and the contents of this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Stifel Nicolaus Europe Limited nor for providing advice in connection with the Placing and the contents of this announcement or any other matter referred to herein.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCAKADDDBKDFOK
Date   Source Headline
10th Jul 20177:00 amRNSPlacing under Placing Programme
6th Jun 20173:31 pmRNSDirector/PDMR Shareholding
2nd Jun 201711:18 amRNSDirector/PDMR Shareholding
2nd Jun 201711:18 amRNSTotal Voting Rights
25th May 20177:00 amRNSHalf-yearly report and financial statements 2017
24th May 201710:51 amRNSAdditional Listing
8th May 20174:52 pmRNSSCRIP Dividend Circular
2nd May 201710:22 amRNSInvestor Report - 31 March 2017
2nd May 20179:26 amRNSInvestor Report - 31 March 2017
26th Apr 20172:35 pmRNSAdditional investment commitment of up to £40.0m
20th Apr 201712:57 pmRNSDividend Declaration & Scrip Dividend Alternative
20th Apr 201710:18 amRNSConditional investment commitment
20th Apr 20178:11 amRNSNovation of investment advisory agreement
10th Apr 20173:52 pmRNSNet Asset Value(s)
28th Mar 20174:21 pmRNSPublication of a Prospectus
8th Mar 20172:39 pmRNSDirector/PDMR Shareholding
3rd Mar 201710:26 amRNSDirector/PDMR Shareholding
3rd Mar 201710:24 amRNSTotal Voting Rights
21st Feb 201710:45 amRNSAdditional Listing
13th Feb 20174:58 pmRNSReplacement: Result of AGM
10th Feb 20173:57 pmRNSResult of EGM
10th Feb 20173:54 pmRNSResult of AGM
3rd Feb 20174:56 pmRNSSCRIP Dividend Circular
30th Jan 20171:26 pmRNSInvestor Report - 31 December 2016
18th Jan 20173:44 pmRNSRevolving Credit Facility
17th Jan 20175:31 pmRNSNew Directorship Notification
17th Jan 20172:11 pmRNSDividend Declaration
10th Jan 20177:00 amRNSNet Asset Value(s)
5th Jan 20174:59 pmRNSNotice of AGM & EGM
14th Dec 20163:03 pmRNSNotification of Major Interest in Shares
14th Dec 201611:38 amRNSReplacement Annual Financial Report
14th Dec 20167:15 amRNSPublication of Supplementary Prospectus
14th Dec 20167:00 amRNSAnnual Report and Financial Statements
9th Dec 20164:53 pmRNSDirector/PDMR Shareholding
1st Dec 20169:47 amRNSTotal Voting Rights
29th Nov 20163:29 pmRNSNotification of Major Interest in Shares
29th Nov 20169:56 amRNSResult of Placing and Additional Listing
18th Nov 20167:00 amRNSPlacing under the Placing Programme
15th Nov 20163:08 pmRNSAdditional Listing and Total Voting Rights
1st Nov 20167:00 amRNSScrip Dividend Circular
14th Oct 20161:19 pmRNSReplacement Dividend Declaration & Scrip Dividend
14th Oct 20169:27 amRNSDividend Declaration
13th Oct 20164:13 pmRNSInvestor Report - 30 September 2016
10th Oct 20167:00 amRNSInvestment commitment of up to c.£60.0 million
7th Oct 20165:24 pmRNSNet Asset Value(s)
30th Aug 201610:55 amRNSTotal Voting Rights
17th Aug 20165:19 pmRNSAdditional Listing
1st Aug 20165:00 pmRNSScrip Dividend Circular
29th Jul 201612:00 pmRNSTotal Voting Rights
26th Jul 20164:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.